CHARISMA Suggests Benefit Of Combo Antiplatelet Therapy In Patients With Established CV Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Overall study group, however, did not show reduction in risk in combined rate of death, heart attack or stroke from combination therapy of Plavix and low-dose aspirin.